Insights into HLA-G genetics provided by worldwide haplotype diversity

Frontiers in Immunology

Volumn 5, Issue OCT, 2014, Pages

  Castelli, Erick C ^a   Ramalho, Jaqueline ^a   Porto, Iane O P ^a   Lima, Thálitta H A ^a   Felício, Leandro P ^b   Sabbagh, Audrey ^c,d   Donadi, Eduardo A ^e   Mendes Junior, Celso T ^e  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c Faculté de Pharmacie   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

1000Genomes project; Gene structure and diversity; Haplotypes; HLA G; Non classical HLA; Polymorphisms; Selective pressure; Variability

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA G ANTIGEN; MESSENGER RNA;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; CHROMOSOME 6; EXON; GENE FREQUENCY; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HLA SYSTEM; INTRON; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATION INITIATION;

EID: 84919414787     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00476     Document Type: Article

References (159)

1. Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol (2008) 29(7):313-21. doi:10.1016/j.it.2008.02.012
2. Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci U S A (1987) 84(24):9145-9. doi:10.1073/pnas.84.24.9145
3. Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci (2011) 68(3):369-95. doi:10.1007/s00018-010-0580-7
4. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A (1997) 94(21):11520-5. doi:10.1073/pnas.94.21.11520
5. Horuzsko A, Lenfant F, Munn DH, Mellor AL. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol (2001) 13(3):385-94. doi:10.1093/intimm/13.3.385
6. Kamishikiryo J, Maenaka K. HLA-G molecule. Curr Pharm Des (2009) 15(28):3318-24. doi:10.2174/138161209789105153
7. Shiroishi M, Kuroki K, Ose T, Rasubala L, Shiratori I, Arase H, et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem (2006) 281(15):10439-47. doi:10.1074/jbc. M512305200
8. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med (1999) 189(7):1093-100. doi:10.1084/jem.189.7.1093
9. Sargent IL. Maternal and fetal immune responses during pregnancy. Exp Clin Immunogenet (1993) 10(2):85-102.
10. Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol (2004) 191(2):525-9. doi:10.1016/j.ajog.2004.01.033
11. Peng B, Zhang L, Xing AY, Hu M, Liu SY. [The expression of human leukocyte antigen G and E on human first trimester placenta and its relationship with recurrent spontaneous abortion]. Sichuan Da Xue Xue Bao Yi Xue Ban (2008) 39(6):976-9.
12. Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol (2003) 64(11):1039-44. doi:10.1016/j.humimm.2003.08.346
13. Lefebvre S, Adrian F, Moreau P, Gourand L, Dausset J, Berrih-Aknin S, et al. Modulation of HLA-G expression in human thymic and amniotic epithelial cells. Hum Immunol (2000) 61(11):1095-101. doi:10.1016/S0198-8859(00)00192-0
14. Menier C, Rabreau M, Challier JC, Le Discorde M, Carosella ED, Rouas-Freiss N. Erythroblasts secrete the non-classical HLA-G molecule from primitive to definitive hematopoiesis. Blood (2004) 104(10):3153-60. doi:10.1182/blood-2004-03-0809
15. Cordero EA, Veit TD, da Silva MA, Jacques SM, Silla LM, Chies JA. HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens (2009) 74(4):308-13. doi:10.1111/j.1399-0039.2009.01331.x
16. Haddad R, Ciliao Alves DC, Rocha-Junior MC, Azevedo R, do Socorro Pombo-de-Oliveira M, Takayanagui OM, et al. HLA-G 14-bp insertion/deletion polymorphism is a risk factor for HTLV-1 infection. AIDS Res Hum Retroviruses (2011) 27(3):283-8. doi:10.1089/aid.2010.0165
17. Kim SK, Chung JH, Jeon JW, Park JJ, Cha JM, Joo KR, et al. Association between HLA-G 14-bp insertion/deletion polymorphism and hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection. Hepatogastroenterology (2013) 60(124):796-8. doi:10.5754/hge11180
18. Segat L, Zupin L, Kim HY, Catamo E, Thea DM, Kankasa C, et al. HLA-G 14 bp deletion/insertion polymorphism and mother-to-child transmission of HIV. Tissue Antigens (2014) 83(3):161-7. doi:10.1111/tan.12296
19. Simoes RT, Goncalves MA, Castelli EC, Junior CM, Bettini JS, Discorde ML, et al. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Mod Pathol (2009) 22(8):1075-82. doi:10.1038/modpathol.2009.67
20. da Silva GK, Vianna P, Veit TD, Crovella S, Catamo E, Cordero EA, et al. Influence of HLA-G polymorphisms in human immunodeficiency virus infection and hepatitis C virus co-infection in Brazilian and Italian individuals. Infect Genet Evol (2014) 21:418-23. doi:10.1016/j.meegid.2013.12.013
21. Jeong S, Park S, Park BW, Park Y, Kwon OJ, Kim HS. Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients. PLoS One (2014) 9(5):e98284. doi:10.1371/journal.pone.0098284
22. Chen Y, Gao XJ, Deng YC, Zhang HX. Relationship between HLA-G gene polymorphism and the susceptibility of esophageal cancer in Kazakh and Han nationality in Xinjiang. Biomarkers (2012) 17(1):9-15. doi:10.3109/1354750X.2011.633242
23. Castelli EC, Mendes-Junior CT, Viana de Camargo JL, Donadi EA. HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue Antigens (2008) 72(2):149-57. doi:10.1111/j.1399-0039.2008.01091.x
24. Cao M, Yie SM, Liu J, Ye SR, Xia D, Gao E. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens (2011) 78(2):120-8. doi:10.1111/j.1399-0039.2011.01716.x
25. Dong DD, Yie SM, Li K, Li F, Xu Y, Xu G, et al. Importance of HLA-G expression and tumor infiltrating lymphocytes in molecular subtypes of breast cancer. Hum Immunol (2012) 73(10):998-1004. doi:10.1016/j.humimm.2012.07.321
26. Dunker K, Schlaf G, Bukur J, Altermann WW, Handke D, Seliger B. Expression and regulation of non-classical HLA-G in renal cell carcinoma. Tissue Antigens (2008) 72(2):137-48. doi:10.1111/j.1399-0039.2008.01090.x
27. Kren L, Slaby O, Muckova K, Lzicarova E, Sova M, Vybihal V, et al. Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance? Neuropathology (2011) 31(2):129-34. doi:10.1111/j.1440-1789.2010.01149.x
28. Akhter A, Faridi RM, Das V, Pandey A, Naik S, Agrawal S. In vitro up-regulation of HLA-G using dexamethasone and hydrocortisone in first-trimester trophoblast cells of women experiencing recurrent miscarriage. Tissue Antigens (2012) 80(2):126-35. doi:10.1111/j.1399-0039.2012.01884.x
29. Aldrich CL, Stephenson MD, Karrison T, Odem RR, Branch DW, Scott JR, et al. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod (2001) 7(12):1167-72. doi:10.1093/molehr/7.12.1167
30. Bhalla A, Stone PR, Liddell HS, Zanderigo A, Chamley LW. Comparison of the expression of human leukocyte antigen (HLA)-G and HLA-E in women with normal pregnancy and those with recurrent miscarriage. Reproduction (2006) 131(3):583-9. doi:10.1530/rep.1.00892
31. Christiansen OB, Kolte AM, Dahl M, Larsen EC, Steffensen R, Nielsen HS, et al. Maternal homozygocity for a 14 base pair insertion in exon 8 of the HLA-G gene and carriage of HLA class II alleles restricting HY immunity predispose to unexplained secondary recurrent miscarriage and low birth weight in children born to these patients. Hum Immunol (2012) 73(7):699-705. doi:10.1016/j.humimm.2012.04.014
32. Fan W, Li S, Huang Z, Chen Q. Relationship between HLA-G polymorphism and susceptibility to recurrent miscarriage: a meta-analysis of non-family-based studies. J Assist Reprod Genet (2014) 31(2):173-84. doi:10.1007/s10815-013-0155-2
33. Kolte AM, Steffensen R, Nielsen HS, Hviid TV, Christiansen OB. Study of the structure and impact of human leukocyte antigen (HLA)-G-A, HLA-G-B, and HLA-G-DRB1 haplotypes in families with recurrent miscarriage. Hum Immunol (2010) 71(5):482-8. doi:10.1016/j.humimm.2010.02.001
34. Vargas RG, Sarturi PR, Mattar SB, Bompeixe EP, Silva Jdos S, Pirri A, et al. Association of HLA-G alleles and 3' UTR 14 bp haplotypes with recurrent miscarriage in Brazilian couples. Hum Immunol (2011) 72(6):479-85. doi:10.1016/j.humimm.2011.02.011
35. Zhu Y, Huo Z, Lai J, Li S, Jiao H, Dang J, et al. Case-control study of a HLA-G 14-bp insertion-deletion polymorphism in women with recurrent miscarriages. Scand J Immunol (2010) 71(1):52-4. doi:10.1111/j.1365-3083.2009.02348.x
36. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens (2002) 60(2):122-32. doi:10.1034/j.1399-0039.2002.600202.x
37. Hviid TV. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update (2006) 12(3):209-32. doi:10.1093/humupd/dmi048
38. Larsen MH, Hylenius S, Andersen AM, Hviid TV. The 3'-untranslated region of the HLA-G gene in relation to pre-eclampsia: revisited. Tissue Antigens (2010) 75(3):253-61. doi:10.1111/j.1399-0039.2009.01435.x
39. Hylenius S, Andersen AM, Melbye M, Hviid TV. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod (2004) 10(4):237-46. doi:10.1093/molehr/gah035
40. Hviid TV, Hylenius S, Lindhard A, Christiansen OB. Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens (2004) 64(1):66-9. doi:10.1111/j.1399-0039.2004.00239.x
41. Lin A, Yan WH, Dai MZ, Chen XJ, Li BL, Chen BG, et al. Maternal human leukocyte antigen-G polymorphism is not associated with pre-eclampsia in a Chinese Han population. Tissue Antigens (2006) 68(4):311-6. doi:10.1111/j.1399-0039.2006.00667.x
42. Loisel DA, Billstrand C, Murray K, Patterson K, Chaiworapongsa T, Romero R, et al. The maternal HLA-G 1597DeltaC null mutation is associated with increased risk of pre-eclampsia and reduced HLA-G expression during pregnancy in African-American women. Mol Hum Reprod (2013) 19(3):144-52. doi:10.1093/molehr/gas041
43. O'Brien M, McCarthy T, Jenkins D, Paul P, Dausset J, Carosella ED, et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci (2001) 58(12-13):1943-9. doi:10.1007/PL00000828
44. Tan CY, Ho JF, Chong YS, Loganath A, Chan YH, Ravichandran J, et al. Paternal contribution of HLA-G*0106 significantly increases risk for pre-eclampsia in multigravid pregnancies. Mol Hum Reprod (2008) 14(5):317-24. doi:10.1093/molehr/gan013
45. Yong PJ. Placentology in the world's most livable city: HLA-G, pre-eclampsia and HIF-1. Clin Invest Med (2003) 26(1):10-1.
46. Brenol CV, Veit TD, Chies JA, Xavier RM. The role of the HLA-G gene and molecule on the clinical expression of rheumatologic diseases. Rev Bras Reumatol (2012) 52(1):82-91. doi:10.1590/S0482-50042012000100009
47. Consiglio CR, Veit TD, Monticielo OA, Mucenic T, Xavier RM, Brenol JC, et al. Association of the HLA-G gene + 3142C > G polymorphism with systemic lupus erythematosus. Tissue Antigens (2011) 77(6):540-5. doi:10.1111/j.1399-0039.2011.01635.x
48. Veit TD, Cordero EA, Mucenic T, Monticielo OA, Brenol JC, Xavier RM, et al. Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus. Lupus (2009) 18(5):424-30. doi:10.1177/0961203308098187
49. Veit TD, de Lima CP, Cavalheiro LC, Callegari-Jacques SM, Brenol CV, Brenol JC, et al. HLA-G + 3142 polymorphism as a susceptibility marker in two rheumatoid arthritis populations in Brazil. Tissue Antigens (2014) 83(4):260-6. doi:10.1111/tan.12311
50. Veit TD, Vianna P, Scheibel I, Brenol CV, Brenol JC, Xavier RM, et al. Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis. Tissue Antigens (2008) 71(5):440-6. doi:10.1111/j.1399-0039.2008.01019.x
51. Rizzo R, Hviid TV, Govoni M, Padovan M, Rubini M, Melchiorri L, et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens (2008) 71(6):520-9. doi:10.1111/j.1399-0039.2008.01037.x
52. Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H. Soluble HLA-G in rheumatoid arthritis. Hum Immunol (2006) 67(8):561-7. doi:10.1016/j.humimm.2006.03.023
53. Fabris A, Segat L, Catamo E, Morgutti M, Vendramin A, Crovella S. HLA-G 14 bp deletion/insertion polymorphism in celiac disease. Am J Gastroenterol (2011) 106(1):139-44. doi:10.1038/ajg.2010.340
54. Wisniewski A, Bilinska M, Klimczak A, Wagner M, Majorczyk E, Nowak I, et al. Association of the HLA-G gene polymorphism with multiple sclerosis in a Polish population. Int J Immunogenet (2010) 37(4):307-11. doi:10.1111/j.1744-313X.2010.00926.x
55. Crispim JC, Mendes-Junior CT, Wastowski IJ, Costa R, Castelli EC, Saber LT, et al. Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome. Tissue Antigens (2008) 71(1):35-41. doi:10.1111/j.1399-0039.2007.00961.x
56. Mociornita AG, Lim-Shon J, Joseph JM, Ross HJ, Rao V, Delgado DH. Can HLA-G polymorphisms predict the development of cardiac allograft vasculopathy? Hum Immunol (2013) 74(4):464-7. doi:10.1016/j.humimm.2012.12.014
57. Twito T, Joseph J, Mociornita A, Rao V, Ross H, Delgado DH. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. J Heart Lung Transplant (2011) 30(7):778-82. doi:10.1016/j.healun.2011.01.726
58. Khosrotehrani K, Le DanffC, Reynaud-Mendel B, Dubertret L, Carosella ED, Aractingi S. HLA-G expression in atopic dermatitis. J Invest Dermatol (2001) 117(3):750-2. doi:10.1046/j.0022-202x.2001.01487.x
59. Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol (2001) 22(10):553-5. doi:10.1016/S1471-4906(01)02007-5
60. Aractingi S, Briand N, Le DanffC, Viguier M, Bachelez H, Michel L, et al. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol (2001) 159(1):71-7. doi:10.1016/S0002-9440(10)61675-6
61. Graebin P, Veit TD, Alho CS, Dias FS, Chies JA. Polymorphic variants in exon 8 at the 3' UTR of the HLA-G gene are associated with septic shock in critically ill patients. Crit Care (2012) 16(5):R211. doi:10.1186/cc11845
62. Nakagawa S, Niimura Y, Gojobori T, Tanaka H, Miura K. Diversity of preferred nucleotide sequences around the translation initiation codon in eukaryote genomes. Nucleic Acids Res (2008) 36(3):861-71. doi:10.1093/nar/gkm1102
63. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol (1994) 153(12):5516-24.
64. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A (1992) 89(9):3947-51. doi:10.1073/pnas.89.9.3947
65. Paul P, Cabestre FA, Ibrahim EC, Lefebvre S, Khalil-Daher I, Vazeux G, et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol (2000) 61(11):1138-49. doi:10.1016/S0198-8859(00)00197-X
66. Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature (2012) 491(7422):56-65. doi:10.1038/nature11632
67. Castelli EC, Veiga-Castelli LC, Yaghi L, Moreau P, Donadi EA. Transcriptional and posttranscriptional regulations of the HLA-G gene. J Immunol Res (2014) 2014:734068. doi:10.1155/2014/734068
68. Santos KE, Lima TH, Felicio LP, Massaro JD, Palomino GM, Silva AC, et al. Insights on the HLA-G evolutionary history provided by a nearby Alu insertion. Mol Biol Evol (2013) 30(11):2423-34. doi:10.1093/molbev/mst142
69. Sabbagh A, Luisi P, Castelli EC, Gineau L, Courtin D, Milet J, et al. Worldwide genetic variation at the 3' untranslated region of the HLA-G gene: balancing selection influencing genetic diversity. Genes Immun (2014) 15(2):95-106. doi:10.1038/gene.2013.67
70. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment/map format and SAMtools. Bioinformatics (2009) 25(16):2078-9. doi:10.1093/bioinformatics/btp352
71. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 25(14):1754-60. doi:10.1093/bioinformatics/btp324
72. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res (2010) 20(9):1297-303. doi:10.1101/gr.107524.110
73. Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, et al. The variant call format and VCFtools. Bioinformatics (2011) 27(15):2156-8. doi:10.1093/bioinformatics/btr330
74. Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (2012) 6(2):80-92. doi:10.4161/fly.19695
75. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet (2001) 68(4):978-89. doi:10.1086/319501
76. Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Roger M, Moreau P, Donadi EA. A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Mol Biol Evol (2011) 28(11):3069-86. doi:10.1093/molbev/msr138
77. Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Pereira NF, Petzl-Erler ML, Donadi EA. Evaluation of computational methods for the reconstruction of HLA haplotypes. Tissue Antigens (2010) 76(6):459-66. doi:10.1111/j.1399-0039.2010.01539.x
78. Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online (2005) 1:47-50.
79. Excoffier L, Lischer HE. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour (2010) 10(3):564-7. doi:10.1111/j.1755-0998.2010.02847.x
80. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics (1992) 48(2):361-72. doi:10.2307/2532296
81. Weir BS, Cockerham CC. Estimating F-statistics for the analysis of population-structure. Evolution (1984) 38(6):1358-70. doi:10.2307/2408641
82. Raymond M, Rousset F. An exact test for population differentiation. Evolution (1995) 49(6):1280-3. doi:10.2307/2410454
83. Excoffier L, Smouse PE, Quattro JM. Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics (1992) 131(2):479-91.
84. Reynolds J, Weir BS, Cockerham CC. Estimation of the coancestry coefficient: basis for a short-term genetic distance. Genetics (1983) 105(3):767-79.
85. Matte C, Lacaille J, Zijenah L, Ward B, Roger M, Group ZS. HLA-G exhibits low level of polymorphism in indigenous East Africans. Hum Immunol (2002) 63(6):495-501. doi:10.1016/S0198-8859(02)00391-9
86. Ishitani A, Kishida M, Sageshima N, Yashiki S, Sonoda S, Hayami M, et al. Re-examination of HLA-G polymorphism in African Americans. Immunogenetics (1999) 49(9):808-11. doi:10.1007/s002510050555
87. Castelli EC, Mendes-Junior CT, Donadi EA. HLA-G alleles and HLA-G 14 bp polymorphisms in a Brazilian population. Tissue Antigens (2007) 70(1):62-8. doi:10.1111/j.1399-0039.2007.00855.x
88. Castelli EC, Mendes-Junior CT, Deghaide NHS, de Albuquerque RS, Muniz YCN, Simões RT, et al. The genetic structure of 3'untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun (2010) 11(2):134-41. doi:10.1038/gene.2009.74
89. Mendes-Junior CT, Castelli EC, Meyer D, Simoes AL, Donadi EA. Genetic diversity of the HLA-G coding region in Amerindian populations from the Brazilian Amazon: a possible role of natural selection. Genes Immun (2013) 14(8):518-26. doi:10.1038/gene.2013.47
90. Rolfsen GB, Castelli EC, Donadi EA, Duarte RA, Soares CP. HLA-G polymorphism and breast cancer. Int J Immunogenet (2014) 41(2):143-8. doi:10.1111/iji.12092
91. Abbas A, Tripathi P, Naik S, Agrawal S. Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions. Eur J Immunogenet (2004) 31(6):275-8. doi:10.1111/j.1365-2370.2004.00487.x
92. Pirri A, Contieri FC, Benvenutti R, Bicalho Mda G. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors. Transpl Immunol (2009) 20(3):143-9. doi:10.1016/j.trim.2008.09.012
93. Sipak-Szmigiel O, Cybulski C, Wokolorczyk D, Lubinski J, Kurzawa R, Baczkowski T, et al. HLA-G polymorphism and in vitro fertilization failure in a Polish population. Tissue Antigens (2009) 73(4):348-52. doi:10.1111/j.1399-0039.2008.01205.x
94. Sipak-Szmigiel O, Cybulski C, Lubinski J, Ronin-Walknowska E. HLA-G polymorphism in a Polish population and reproductive failure. Tissue Antigens (2008) 71(1):67-71. doi:10.1111/j.1399-0039.2007.00942.x
95. Ober C, Rosinsky B, Grimsley C, van der Ven K, Robertson A, Runge A. Population genetic studies of HLA-G: allele frequencies and linkage disequilibrium with HLA-A1. J Reprod Immunol (1996) 32(2):111-23. doi:10.1016/S0165-0378(96)01000-5
96. van der Ven K, Ober C. HLA-G polymorphisms in African Americans. J Immunol (1994) 153(12):5628-33.
97. van der Ven K, Skrablin S, Ober C, Krebs D. HLA-G polymorphisms: ethnic differences and implications for potential molecule function. Am J Reprod Immunol (1998) 40(3):145-57. doi:10.1111/j.1600-0897.1998.tb00406.x
98. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics (2003) 55(2):63-79. doi:10.1007/s00251-003-0547-z
99. Hviid TV, Meldgaard M, Sorensen S, Morling N. Polymorphism of exon 3 of the HLA-G gene. J Reprod Immunol (1997) 35(1):31-42. doi:10.1016/S0165-0378(97)00051-X
100. Hviid TV, Milman N, Hylenius S, Jakobsen K, Jensen MS, Larsen LG. HLA-G polymorphisms and HLA-G expression in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2006) 23(1):30-7.
101. Yan WH, Fan LA, Yang JQ, Xu LD, Ge Y, Yao FJ. HLA-G polymorphism in a Chinese Han population with recurrent spontaneous abortion. Int J Immunogenet (2006) 33(1):55-8. doi:10.1111/j.1744-313X.2006.00567.x
102. Yan WH, Lin A, Chen XJ, Dai MZ, Gan LH, Zhou MY, et al. Association of the maternal 14-bp insertion polymorphism in the HLA-G gene in women with recurrent spontaneous abortions. Tissue Antigens (2006) 68(6):521-3. doi:10.1111/j.1399-0039.2006.00723.x
103. Kuroshli Z, Gourabi H, Bazrgar M, Sanati MH, Bahraminejad E, Anisi K. HLA-G allele and haplotype frequencies in a healthy population of Iran. Iran J Allergy Asthma Immunol (2014) 13(3):207-13.
104. Metcalfe S, Roger M, Faucher MC, Coutlee F, Franco EL, Brassard P. The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec. Hum Immunol (2013) 74(12):1610-5. doi:10.1016/j.humimm.2013.08.279
105. Alvarez M, Piedade J, Balseiro S, Ribas G, Regateiro F. HLA-G 3'-UTR SNP and 14-bp deletion polymorphisms in Portuguese and Guinea-Bissau populations. Int J Immunogenet (2009) 36(6):361-6. doi:10.1111/j.1744-313X.2009.00875.x
106. Yie SM, Li LH, Xiao R, Librach CL. A single base-pair mutation in the 3'-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod (2008) 14(11):649-53. doi:10.1093/molehr/gan059
107. Sizzano F, Testi M, Zito L, Crocchiolo R, Troiano M, Mazzi B, et al. Genotypes and haplotypes in the 3' untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia. Tissue Antigens (2012) 79(5):326-32. doi:10.1111/j.1399-0039.2012.01862.x
108. Sabbagh A, Courtin D, Milet J, Massaro JD, Castelli EC, Migot-Nabias F, et al. Association of HLA-G 3' untranslated region polymorphisms with antibody response against Plasmodium falciparum antigens: preliminary results. Tissue Antigens (2013) 82(1):53-8. doi:10.1111/tan.12140
109. Martelli-Palomino G, Pancotto JA, Muniz YC, Mendes-Junior CT, Castelli EC, Massaro JD, et al. Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential HLA-G soluble levels in the Brazilian and French population. PLoS One (2013) 8(10):e71742. doi:10.1371/journal.pone.0071742
110. Lucena-Silva N, Monteiro AR, de Albuquerque RS, Gomes RG, Mendes-Junior CT, Castelli EC, et al. Haplotype frequencies based on eight polymorphic sites at the 3' untranslated region of the HLA-G gene in individuals from two different geographical regions of Brazil. Tissue Antigens (2012) 79(4):272-8. doi:10.1111/j.1399-0039.2012.01842.x
111. Lucena-Silva N, de Souza VS, Gomes RG, Fantinatti A, Muniz YC, de Albuquerque RS, et al. HLA-G 3' untranslated region polymorphisms are associated with systemic lupus erythematosus in 2 Brazilian populations. J Rheumatol (2013) 40(7):1104-13. doi:10.3899/jrheum.120814
112. Larsen MH, Zinyama R, Kallestrup P, Gerstoft J, Gomo E, Thorner LW, et al. HLA-G 3' untranslated region 14-base pair deletion: association with poor survival in an HIV-1-infected Zimbabwean population. J Infect Dis (2013) 207(6):903-6. doi:10.1093/infdis/jis924
113. Hviid TV, Rizzo R, Melchiorri L, Stignani M, Baricordi OR. Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum Immunol (2006) 67(1-2):53-62. doi:10.1016/j.humimm.2005.12.003
114. Ciliao Alves DC, de Oliveira Crispim JC, Castelli EC, Mendes-Junior CT, Deghaide NH, Barros Silva GE, et al. Human leukocyte antigen-G 3' untranslated region polymorphisms are associated with better kidney allograft acceptance. Hum Immunol (2012) 73(1):52-9. doi:10.1016/j.humimm.2011.10.007
115. Mendes-Junior CT, Castelli EC, Simoes RT, Simoes AL, Donadi EA. HLA-G 14-bp polymorphism at exon 8 in Amerindian populations from the Brazilian Amazon. Tissue Antigens (2007) 69(3):255-60. doi:10.1111/j.1399-0039.2006.00797.x
116. Garcia A, Milet J, Courtin D, Sabbagh A, Massaro JD, Castelli EC, et al. Association of HLA-G 3'UTR polymorphisms with response to malaria infection: a first insight. Infect Genet Evol (2013) 16:263-9. doi:10.1016/j.meegid.2013.02.021
117. Courtin D, Milet J, Sabbagh A, Massaro JD, Castelli EC, Jamonneau V, et al. HLA-G 3' UTR-2 haplotype is associated with Human African trypanosomiasis susceptibility. Infect Genet Evol (2013) 17:1-7. doi:10.1016/j.meegid.2013.03.004
118. Tan Z, Shon AM, Ober C. Evidence of balancing selection at the HLA-G promoter region. Hum Mol Genet (2005) 14(23):3619-28. doi:10.1093/hmg/ddi389
119. Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, Gray HL, et al. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet (2003) 72(6):1425-35. doi:10.1086/375501
120. Ober C, Billstrand C, Kuldanek S, Tan Z. The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells. Hum Reprod (2006) 21(7):1743-8. doi:10.1093/humrep/del036
121. Veit TD, Cazarolli J, Salzano FM, Schiengold M, Chies JA. New evidence for balancing selection at the HLA-G locus in South Amerindians. Genet Mol Biol (2012) 35(4 Suppl):919-23. doi:10.1590/S1415-47572012000600005
122. Green RE, Krause J, Briggs AW, Maricic T, Stenzel U, Kircher M, et al. A draft sequence of the Neandertal genome. Science (2010) 328(5979):710-22. doi:10.1126/science.1188021
123. Rosenberg NA. A population-genetic perspective on the similarities and differences among worldwide human populations. Hum Biol (2011) 83(6):659-84. doi:10.3378/027.083.0601
124. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature (2001) 409(6822):928-33. doi:10.1038/35057149
125. Vogel TU, Evans DT, Urvater JA, O'Connor DH, Hughes AL, Watkins DI. Major histocompatibility complex class I genes in primates: co-evolution with pathogens. Immunol Rev (1999) 167:327-37. doi:10.1111/j.1600-065X.1999.tb01402.x
126. Watkins DI. The evolution of major histocompatibility class I genes in primates. Crit Rev Immunol (1995) 15(1):1-29. doi:10.1615/CritRevImmunol.v15.i1.10
127. Watkins DI, Chen ZW, Hughes AL, Evans MG, Tedder TF, Letvin NL. Evolution of the MHC class I genes of a new world primate from ancestral homologues of human non-classical genes. Nature (1990) 346(6279):60-3. doi:10.1038/346060a0
128. Arnaiz-Villena A, Martinez-Laso J, Alvarez M, Castro MJ, Varela P, Gomez-Casado E, et al. Primate Mhc-E and -G alleles. Immunogenetics (1997) 46(4):251-66. doi:10.1007/s002510050271
129. Arnaiz-Villena A, Martinez-Laso J, Serrano-Vela JI, Reguera R, Moscoso J. HLA-G polymorphism and evolution. Tissue Antigens (2007) 69(Suppl 1):156-9. doi:10.1111/j.1399-0039.2006.763_8.x
130. Arnaiz-Villena A, Morales P, Gomez-Casado E, Castro MJ, Varela P, Rojo-Amigo R, et al. Evolution of MHC-G in primates: a different kind of molecule for each group of species. J Reprod Immunol (1999) 43(2):111-25. doi:10.1016/S0165-0378(99)00026-1
131. Parga-Lozano C, Reguera R, Gomez-Prieto P, Arnaiz-Villena A. Evolution of major histocompatibility complex G and C and natural killer receptors in primates. Hum Immunol (2009) 70(12):1035-40. doi:10.1016/j.humimm.2009.07.017
132. Bainbridge DR. Evolution of mammalian pregnancy in the presence of the maternal immune system. Rev Reprod (2000) 5(2):67-74. doi:10.1530/ror.0.0050067
133. Castro MJ, Morales P, Fernandez-Soria V, Suarez B, Recio MJ, Alvarez M, et al. Allelic diversity at the primate Mhc-G locus: exon 3 bears stop codons in all Cercopithecinae sequences. Immunogenetics (1996) 43(6):327-36. doi:10.1007/BF02199801
134. Castro MJ, Morales P, Martinez-Laso J, Allende L, Rojo-Amigo R, Gonzalez-Hevilla M, et al. Evolution of MHC-G in humans and primates based on three new 3'UT polymorphisms. Hum Immunol (2000) 61(11):1157-63. doi:10.1016/S0198-8859(00)00188-9
135. van den Elsen PJ, Gobin SJ, van Eggermond MC, Peijnenburg A. Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics (1998) 48(3):208-21. doi:10.1007/s002510050425
136. Gobin SJ, Keijsers V, Cheong C, van Zutphen M, Van den Elsen PJ. Transcriptional regulation of HLA-G. Transplant Proc (1999) 31(4):1857-9. doi:10.1016/S0041-1345(99)00188-8
137. Gobin SJ, Keijsers V, van Zutphen M, van den Elsen PJ. The role of enhancer A in the locus-specific transactivation of classical and non-classical HLA class I genes by nuclear factor kappa B. J Immunol (1998) 161(5):2276-83.
138. Gobin SJ, van Zutphen M, Woltman AM, van den Elsen PJ. Transactivation of classical and non-classical HLA class I genes through the IFN-stimulated response element. J Immunol (1999) 163(3):1428-34.
139. Gobin SJ, van den Elsen PJ. Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G. Hum Immunol (2000) 61(11):1102-7. doi:10.1016/S0198-8859(00)00198-1
140. Steimle V, Durand B, Barras E, Zufferey M, Hadam MR, Mach B, et al. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev (1995) 9(9):1021-32. doi:10.1101/gad.9.9.1021
141. Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, et al. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J (1997) 16(5):1045-55. doi:10.1093/emboj/16.5.1045
142. Gobin SJ, Biesta P, de Steenwinkel JE, Datema G, van den Elsen PJ. HLA-G transactivation by cAMP-response element-binding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class I regulatory routes. J Biol Chem (2002) 277(42):39525-31. doi:10.1074/jbc. M112273200
143. Gobin SJ, Peijnenburg A, Keijsers V, van den Elsen PJ. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity (1997) 6(5):601-11. doi:10.1016/S1074-7613(00)80348-9
144. Lefebvre S, Moreau P, Dausset J, Carosella ED, Paul P. Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA. Placenta (1999) 20(4):293-301. doi:10.1053/plac.1998.0380
145. Rousseau P, Masternak K, Krawczyk M, Reith W, Dausset J, Carosella ED, et al. In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner. Immunology (2004) 111(1):53-65. doi:10.1111/j.1365-2567.2004.01783.x
146. Solier C, Mallet V, Lenfant F, Bertrand A, Huchenq A, Le Bouteiller P. HLA-G unique promoter region: functional implications. Immunogenetics (2001) 53(8):617-25. doi:10.1007/s00251-001-0373-0
147. Ibrahim EC, Morange M, Dausset J, Carosella ED, Paul P. Heat shock and arsenite induce expression of the non-classical class I histocompatibility HLA-G gene in tumor cell lines. Cell Stress Chaperones (2000) 5(3):207-18. doi:10.1379/1466-1268(2000)005<0207:HSAAIE>2.0.CO;2
148. Yie SM, Xiao R, Librach CL. Progesterone regulates HLA-G gene expression through a novel progesterone response element. Hum Reprod (2006) 21(10):2538-44. doi:10.1093/humrep/del126
149. Bamberger AM, Jenatschke S, Schulte HM, Loning T, Bamberger MC. Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells. J Clin Endocrinol Metab (2000) 85(10):3932-6. doi:10.1210/jcem.85.10.6849
150. Rizzo R, Rubini M, Govoni M, Padovan M, Melchiorri L, Stignani M, et al. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics (2006) 16(9):615-23. doi:10.1097/01.fpc.0000230115.41828.3a
151. Shido F, Ito T, Nomura S, Yamamoto E, Sumigama S, Ino K, et al. Endoplasmic reticulum aminopeptidase-1 mediates leukemia inhibitory factor-induced cell surface human leukocyte antigen-G expression in JEG-3 choriocarcinoma cells. Endocrinology (2006) 147(4):1780-8. doi:10.1210/en.2005-1449
152. Onno M, Amiot L, Bertho N, Drenou B, Fauchet R. CpG methylation patterns in the 5' part of the non-classical HLA-G gene in peripheral blood CD34 + cells and CD2 + lymphocytes. Tissue Antigens (1997) 49(4):356-64. doi:10.1111/j.1399-0039.1997.tb02763.x
153. Moreau P, Mouillot G, Rousseau P, Marcou C, Dausset J, Carosella ED. HLA-G gene repression is reversed by demethylation. Proc Natl Acad Sci U S A (2003) 100(3):1191-6. doi:10.1073/pnas.0337539100
154. Harrison GA, Humphrey KE, Jakobsen IB, Cooper DW. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet (1993) 2(12):2200. doi:10.1093/hmg/2.12.2200-a
155. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics (2004) 56(3):135-41. doi:10.1007/s00251-004-0673-2
156. Svendsen SG, Hantash BM, Zhao L, Faber C, Bzorek M, Nissen MH, et al. The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3'-untranslated region. Hum Immunol (2013) 74(7):818-27. doi:10.1016/j.humimm.2013.03.003
157. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol (2003) 64(11):1005-10. doi:10.1016/j.humimm.2003.08.347
158. Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L, et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet (2007) 81(4):829-34. doi:10.1086/521200
159. Castelli EC, Moreau P, Oya e Chiromatzo A, Mendes-Junior CT, Veiga-Castelli LC, Yaghi L, et al. In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum Immunol (2009) 70(12):1020-5. doi:10.1016/j.humimm.2009.07.028